Larry Visits Aldevron, proud sponsor of FRAXA Biotech Games
Aldevron was an inaugural sponsor of the FRAXA Biotech Games and continued its involvement in 2019 to support the FRAXA Research Foundation. The foundation funds research into Fragile X, the most common inherited cause of autism.
Jessica Haugen of Thompson, ND, is a board member for FRAXA, and her son, Larry, was diagnosed with Fragile X at 18 months. She visited Aldevron to discuss the disease and introduce her son to company employees.
Видео Larry Visits Aldevron, proud sponsor of FRAXA Biotech Games канала Aldevron
Jessica Haugen of Thompson, ND, is a board member for FRAXA, and her son, Larry, was diagnosed with Fragile X at 18 months. She visited Aldevron to discuss the disease and introduce her son to company employees.
Видео Larry Visits Aldevron, proud sponsor of FRAXA Biotech Games канала Aldevron
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Challenges in Manufacturing AAV in a Phase I Environment: A Practical Approach | Andrew Moreo
Unveiling Aldevron's New Conference Booth (Time Lapse)
Discovery and Characterization of Novel SpCas9 and AsCas12a Mutants | Christopher Vakulskas, Ph.D.
Plasmids for Viral Vectors
Supply Chain for Gene Modified Cell Manufacturing | Tom Foti
Todd Howren, Ph.D., at Meeting on the Mesa
Manufacturing Considerations in Cell Therapy Development | Anne Kantardjieff, Ph.D.
Aldevron's mRNA Capabilities | Nate Spangler, Ph.D.
Gene Editing of Mutant Alleles Using CRISPR-Cas9 Ribonucleoprotein Complexes | Krishanu Saha, Ph.D.
Tour Aldevron's Expanded Facility in Madison, Wisconsin with Tom Foti
A Patient's Perspective | Robert Levis
Broadening the Reach of Gene Therapy by Discovery and Collaboration | Luk Vandenberghe, Ph.D.
Join Team Aldevron: Advance Your Biotech Career in Madison, Wisconsin
Nonviral Synthetic Polymers Promote Cellular and In Vivo Deliveries | Theresa Reineke, Ph.D.
Discover the Power of Small and Safe with Nanoplasmid®
Evaluating Quality Systems with Your Manufacturing Partners
GEN Webinar: The Future of CRISPR Cell Therapies is GMP
A Next-Generation Plasmid Demonstrated to Improve Non-Viral Vector Manufacturing – Nanoplasmidᵀᴹ
Aldevron Campus Expansion Announcement
Ready to Edit: Unique Manufacturing Solutions to Accelerate Your Clinical Development | Max Sellman
Badger Challenge: Pie Your Manager Fundraiser